|
1
|
Ottaviani G, Robert RS, Huh WW, Palla S
and Jaffe N: Sociooccupational and physical outcomes more than 20
years after the diagnosis of osteosarcoma in children and
adolescents: limb salvage versus amputation. Cancer. 119:3727–3736.
2013.PubMed/NCBI
|
|
2
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
|
|
3
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Erhard F, Haas J, Lieber D, et al:
Widespread context dependency of microRNA-mediated regulation.
Genome Res. 24:906–919. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Almeida MI, Reis RM and Calin GA: MicroRNA
history: discovery, recent applications and next frontiers. Mutat
Res. 717:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Z and Wang T: miR-214 promotes the
proliferation and invasion of osteosarcoma cells through direct
suppression of LZTS1. Biochem Biophys Res Commun. 449:190–195.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li E, Zhang J, Yuan T and Ma B: miR-145
inhibits osteosarcoma cells proliferation and invasion by targeting
ROCK1. Tumour Biol. 35:7645–7650. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lulla RR, Costa FF, Bischof JM and Chou
PM: Identification of differentially expressed microRNAs in
osteosarcoma. Sarcoma. 2011:7326902011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cai H, Lin L, Cai H, Tang M and Wang Z:
Prognostic evaluation of microRNA-210 expression in pediatric
osteosarcoma. Med Oncol. 30:4992013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fasanaro P, Greco S, Lorenzi M, et al: An
integrated approach for experimental target identification of
hypoxia-induced miR-210. J Biol Chem. 284:35134–35143. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giannakakis A, Sandaltzopoulos R, Greshock
J, et al: miR-210 links hypoxia with cell cycle regulation and is
deleted in human epithelial ovarian cancer. Cancer Biol Ther.
7:255–264. 2008. View Article : Google Scholar
|
|
17
|
McCormick RI, Blick C, Ragoussis J, et al:
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal
cancer, regulates ISCU and correlates with good prognosis. Br J
Cancer. 108:1133–1142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang X, Ding L, Bennewith KL, Tong RT,
Welford SM, Ang KK, Story M, Le QT and Giaccia AJ:
Hypoxia-inducible mir-210 regulates normoxic gene expression
involved in tumor initiation. Mol Cell. 35:856–867. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takikawa T, Masamune A, Hamada S, Nakano
E, Yoshida N and Shimosegawa T: miR-210 regulates the interaction
between pancreatic cancer cells and stellate cells. Biochem Biophys
Res Commun. 437:433–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Devlin C, Greco S, Martelli F and Ivan M:
miR-210: More than a silent player in hypoxia. IUBMB Life.
63:94–100. 2011.PubMed/NCBI
|
|
21
|
Chan SY and Loscalzo J: MicroRNA-210: a
unique and pleiotropic hypoxamir. Cell Cycle. 9:1072–1083. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Greither T, Grochola LF, Udelnow A,
Lautenschlager C, Wurl P and Taubert H: Elevated expression of
microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated
with poorer survival. Int J Cancer. 126:73–80. 2010. View Article : Google Scholar
|
|
23
|
Gee HE, Camps C, Buffa FM, et al:
hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in
head and neck cancer. Cancer. 116:2148–2158. 2010.PubMed/NCBI
|
|
24
|
Foekens JA, Sieuwerts AM, Smid M, et al:
Four miRNAs associated with aggressiveness of lymph node-negative,
estrogen receptor-positive human breast cancer. Proc Natl Acad Sci
USA. 105:13021–13026. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Puissegur MP, Mazure NM, Bertero T, et al:
miR-210 is overexpressed in late stages of lung cancer and mediates
mitochondrial alterations associated with modulation of HIF-1
activity. Cell Death Differ. 18:465–478. 2011. View Article : Google Scholar :
|
|
26
|
Juan D, Alexe G, Antes T, et al:
Identification of a microRNA panel for clear-cell kidney cancer.
Urology. 75:835–841. 2010. View Article : Google Scholar
|
|
27
|
Eilertsen M, Andersen S, Al-Saad S, et al:
Positive prognostic impact of miR-210 in non-small cell lung
cancer. Lung Cancer. 83:272–278. 2014. View Article : Google Scholar
|
|
28
|
Ying Q, Liang L, Guo W, et al:
Hypoxia-inducible microRNA-210 augments the metastatic potential of
tumor cells by targeting vacuole membrane protein 1 in
hepatocellular carcinoma. Hepatology. 54:2064–2075. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong L, Yang J, Han Y, Lu Q, Cao J and
Syed L: High expression of miR-210 predicts poor survival in
patients with breast cancer: a meta-analysis. Gene. 507:135–138.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wotschofsky Z, Busch J, Jung M, et al:
Diagnostic and prognostic potential of differentially expressed
miRNAs between metastatic and non-metastatic renal cell carcinoma
at the time of nephrectomy. Clin Chim Acta. 416:5–10. 2013.
View Article : Google Scholar
|
|
31
|
Qu A, Du L, Yang Y, et al:
Hypoxia-inducible MiR-210 is an independent prognostic factor and
contributes to metastasis in colorectal cancer. PLoS One.
9:e909522014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Giannakakis A, Sandaltzopoulos R, Greshock
J, et al: miR-210 links hypoxia with cell cycle regulation and is
deleted in human epithelial ovarian cancer. Cancer Biol Ther.
7:255–264. 2008. View Article : Google Scholar
|
|
33
|
Tsuchiya S: The role of microRNA-210 in
esophageal squamous cell carcinoma. Yakugaku Zasshi. 132:1069–1073.
2012.In Japanese. View Article : Google Scholar
|
|
34
|
Mizuno Y, Tokuzawa Y, Ninomiya Y, et al:
miR-210 promotes osteoblastic differentiation through inhibition of
AcvR1b. FEBS Lett. 583:2263–2268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chan YC, Banerjee J, Choi SY and Sen CK:
miR-210: the master hypoxamir. Microcirculation. 19:215–223. 2012.
View Article : Google Scholar :
|
|
36
|
Mei Y, Gao C, Wang K, et al: Effect of
microRNA-210 on prognosis and response to chemotherapeutic drugs in
pediatric acute lymphoblastic leukemia. Cancer Sci. 105:463–472.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qin Q, Furong W and Baosheng L: Multiple
functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer
Res. 33:502014. View Article : Google Scholar : PubMed/NCBI
|
